INTEGRATIVE HEALTH TECHNOLOGIES, INC. Inactive Instrument
Integrative Health Technologies, Inc. Stock Other OTC
Equities
IHTI
US45822A2078
Biotechnology & Medical Research
Financials (USD)
| Sales 2008 | 0.43 | Sales 2009 | 0.45 | Capitalization | 1.22M |
|---|---|---|---|---|---|
| Net income 2008 | - | Net income 2009 | - | EV / Sales 2008 | 14,379,727 x |
| Net Debt 2008 | 99.02K | Net Debt 2009 | 94.3K | EV / Sales 2009 | 2,939,517 x |
| P/E ratio 2008 |
231
x | P/E ratio 2009 |
31.6
x | Employees | - |
| Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 48.33% |
More Fundamentals
* Assessed data
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Samuel C. Keith
CIO | Chief Investment Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Integrative Health Technologies, Inc. operates as an independent clinical research organization (CRO) providing pilot studies and clinical trials of non-pharmaceutical products and plans for the medical, biotech and nutritional supplement industries. The Company is providing pilot studies and clinical trials of non-pharmaceutical products. The Company is building a longitudinal database of medical biomarkers for analysis of inter-and intra-relationships between A 45 -panel of fasting blood chemistries, dual energy x-ray absorptiometry (DEXA) total body scans of fat, and lean and bone density/bone mineral content for the medical, biotech and nutritional supplement industries.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.20% | 42.11B | |
| +48.83% | 40.08B | |
| +8.00% | 40B | |
| -10.82% | 26.87B | |
| +7.15% | 24.58B | |
| -23.80% | 18.44B | |
| +1.39% | 11.94B | |
| +30.96% | 11.66B | |
| +7.40% | 11.01B |
